JP2007522243A5 - - Google Patents

Download PDF

Info

Publication number
JP2007522243A5
JP2007522243A5 JP2006553327A JP2006553327A JP2007522243A5 JP 2007522243 A5 JP2007522243 A5 JP 2007522243A5 JP 2006553327 A JP2006553327 A JP 2006553327A JP 2006553327 A JP2006553327 A JP 2006553327A JP 2007522243 A5 JP2007522243 A5 JP 2007522243A5
Authority
JP
Japan
Prior art keywords
fgfr
composition
fgf
sulf1
fgf4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006553327A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007522243A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/004682 external-priority patent/WO2005079390A2/en
Publication of JP2007522243A publication Critical patent/JP2007522243A/ja
Publication of JP2007522243A5 publication Critical patent/JP2007522243A5/ja
Pending legal-status Critical Current

Links

JP2006553327A 2004-02-13 2005-02-11 Fgfシグナリングの阻害 Pending JP2007522243A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54444904P 2004-02-13 2004-02-13
PCT/US2005/004682 WO2005079390A2 (en) 2004-02-13 2005-02-11 Inhibition of fgf signaling

Publications (2)

Publication Number Publication Date
JP2007522243A JP2007522243A (ja) 2007-08-09
JP2007522243A5 true JP2007522243A5 (enExample) 2008-03-21

Family

ID=34886037

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553327A Pending JP2007522243A (ja) 2004-02-13 2005-02-11 Fgfシグナリングの阻害

Country Status (5)

Country Link
US (1) US7968527B2 (enExample)
EP (1) EP1742961A4 (enExample)
JP (1) JP2007522243A (enExample)
CA (1) CA2555417A1 (enExample)
WO (1) WO2005079390A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200914044A (en) * 2007-07-12 2009-04-01 Daiichi Sankyo Co Ltd Anti human Sulf1 antibody
WO2009011892A2 (en) * 2007-07-18 2009-01-22 Boston Biomedical Research Institute Use of suif proteins and heparan sulfate in gdnf-dependent neural innervation and protection
WO2010003023A2 (en) * 2008-07-01 2010-01-07 Zacharon Pharmaceuticals, Inc. Heparan sulfate inhibitors
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
JP5784296B2 (ja) * 2010-10-01 2015-09-24 学校法人 創価大学 神経細胞の製造方法及び神経細胞分化促進剤
KR20150123250A (ko) 2013-03-06 2015-11-03 제넨테크, 인크. 암 약물 내성의 치료 및 예방 방법
JP2017517552A (ja) 2014-06-13 2017-06-29 ジェネンテック, インコーポレイテッド 抗癌剤耐性の治療及び防止方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1206234A4 (en) * 1999-06-03 2005-06-01 Jessie L S Au METHODS AND COMPOSITIONS FOR MODULATING PROLIFERATION AND CELL DEATH
US7129072B1 (en) * 1999-08-30 2006-10-31 New York University Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
US20030147875A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
WO2003012053A2 (en) * 2001-08-01 2003-02-13 New York University Identification of receptor and heparin binding sites in fgf4 by structure-based mutagenesis

Similar Documents

Publication Publication Date Title
ATE447568T1 (de) Neue pyrinderivate
JP2009524695A5 (enExample)
ATE432323T1 (de) Bitumenzusammensetzung
UA100252C2 (uk) Композиція будівельного матеріалу та її застосування
MY154909A (en) Novel thiophene derivatives
JP2008501714A5 (enExample)
TW200716591A (en) Novel thiophene derivatives
NO20080897L (no) Salter av 4-metyl-N-[3-(4-metylimidazol-1-yl)-5-trifluormetylfenyl]-3-(4-pyridin-3-ylpyrimidin-2-ylamino)benzamid
JP2007525551A5 (enExample)
TW200708511A (en) Novel thiophene derivatives
WO2007017423A3 (en) Pharmaceutical composition comprising a dpp-iv inhibitor
EP2252274A1 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2008019871A3 (de) Neue salze des wirkstoffs rasagilin
WO2006065479A3 (en) Substituted phenols as active agents inhibiting vegf production
EP2140883A4 (en) NEW BASIS FOR A DRY SOLID DISPERSION, THE SOLID DISPERSION CONTAINING BASE, AND THE COMPOSITION CONTAINING THE DISPERSION
WO2010042417A3 (en) Waste storage vessels and compositions therefor
TW200738670A (en) Novel thiophene derivatives
JP2011503300A5 (enExample)
WO2008028954A3 (en) Novel compounds and compositions thereof
MX2008014227A (es) Amortiguador del sonido de aplicacion liquida.
NO20060021L (no) Trelim
PL1931310T3 (pl) Jednofazowa kompozycja błonotwórcza do miejscowego stosowania
WO2006103277A3 (en) 2 , 4 , 5-substituted piperidines as renin inhibitors
WO2010076093A3 (de) Säurebausteine und verschiedenartige polyetherbausteine enthaltendes copolymer
JP2007522243A5 (enExample)